European regulators have cleared the way for GlaxoSmithKline to sell an over-the-counter version of Xenical, Roche's prescription-only medicine for obesity.
The European Medicines Agency said on Friday its experts had recommended granting marketing authorisation for Glaxo's low-dose version of orlistat -- the active ingredient in Xenical -- based on the safety and efficacy of Roche's original product.
Glaxo's non-prescription drug was approved in February in the United States, where it is being launched under the brand name "alli".
There is no truth in the rumor that the EU version is to be called "allez"!
Source
No comments:
Post a Comment